Myrna Dolovich

Prof. Myrna Dolovich


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2005 in Chest
Verified
Journal Article
Closed access
PDF file
MDMyrna Dolovich
Myrna Dolovich
RARichard C. Ahrens
Richard C. Ahrens
DHDean R. Hess
Dean R. Hess
PAPaula Anderson
Paula Anderson
RDRajiv Dhand
Rajiv Dhand
GGGordon Guyatt
Gordon Guyatt

1 March 2011 in The Lancet
Verified
Journal Article
Closed access
MDMyrna Dolovich
Myrna Dolovich
RDRajiv Dhand
Rajiv Dhand

11 November 2016 in Cells
Verified
Journal Article
Open access
PDF file
AYAsma Yaghi
Asma Yaghi
MDMyrna Dolovich
Myrna Dolovich
Airway epithelium is the first line of defense against exposure of the airway and lung to various inflammatory stimuli. Ciliary beating of airway epithelial cells constitutes an important part of the mucociliary transport apparatus. To be effective in transporting secretions out of the lung, the mucociliary transport apparatus must exhibit a cohesive beating of all ciliated epithelial cells that line the upper and lower respiratory tract. Cilia function can be modulated by exposures to endogenous and exogenous factors and by the viscosity of the mucus lining the epithelium. Cilia function is impaired in lung diseases such as COPD and asthma, and pharmacologic agents can modulate cilia function and mucus viscosity. Cilia beating is reduced in COPD, however, more research is needed to determine the structural-functional regulation of ciliary beating via all signaling pathways and how this might relate to the initiation or progression of obstructive lung diseases. Additionally, genotypes and how these can influence phenotypes and epithelial cell cilia function and structure should be taken into consideration in future investigations.

8 February 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
MJMangalakumari Jeyanathan
Mangalakumari Jeyanathan
DFDominik K. Fritz
Dominik K. Fritz
SASam Afkhami
Sam Afkhami
EAEmilio Aguirre
Emilio Aguirre
KHKaren J. Howie
Karen J. Howie
FSFiona Smaill
Fiona Smaill
Background: Adenovirus-vectored (Ad-vectored) vaccines are typically administered via i.m. injection to humans and are incapable of inducing respiratory mucosal immunity. However, aerosol delivery of Ad-vectored vaccines remains poorly characterized, and its ability to induce mucosal immunity in humans is unknown. This phase Ib trial evaluated the safety and immunogenicity of human serotype-5 Ad-vectored tuberculosis (TB) vaccine (AdHu5Ag85A) delivered to humans via inhaled aerosol or i.m. injection. Methods: Thirty-one healthy, previously BCG-vaccinated adults were enrolled. AdHu5Ag85A was administered by single-dose aerosol using Aeroneb Solo Nebulizer or by i.m. injection. The study consisted of the low-dose (LD) aerosol, high-dose (HD) aerosol, and i.m. groups. The adverse events were assessed at various times after vaccination. Immunogenicity data were collected from the peripheral blood and bronchoalveolar lavage samples at baseline, as well as at select time points after vaccination. Results: The nebulized aerosol droplets were < 5.39 μm in size. Both LD and HD of AdHu5Ag85A administered by aerosol inhalation and i.m. injection were safe and well tolerated. Both aerosol doses, particularly LD, but not i.m., vaccination markedly induced airway tissue–resident memory CD4 + and CD8 + T cells of polyfunctionality. While as expected, i.m. vaccination induced Ag85A-specific T cell responses in the blood, the LD aerosol vaccination also elicited such T cells in the blood. Furthermore, the LD aerosol vaccination induced persisting transcriptional changes in alveolar macrophages. Conclusion: Inhaled aerosol delivery of Ad-vectored vaccine is a safe and superior way to elicit respiratory mucosal immunity. This study warrants further development of aerosol vaccine strategies against respiratory pathogens, including TB and COVID-19. Trial registration: ClinicalTrial.gov, NCT02337270. Funding: The Canadian Institutes for Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada funded this work.

15 September 2020 in Annals of Internal Medicine
Verified
Journal Article
Open access
CCCatherine M. Clase
Catherine M. Clase
EFEdouard L. Fu
Edouard L. Fu
MJMeera Joseph
Meera Joseph
RBRupert C.L. Beale
Rupert C.L. Beale
MDMyrna Dolovich
Myrna Dolovich
JCJuan J. Carrero
Juan J. Carrero
As the COVID-19 pandemic progressed across the world, governments, international agencies, policymakers, and public health officials began recommending widespread use of nonmedical cloth masks to r...

1 October 2020 in Mayo Clinic Proceedings
Verified
Journal Article
Open access
CCCatherine M. Clase
Catherine M. Clase
EFEdouard L. Fu
Edouard L. Fu
AAAurneen Ashur
Aurneen Ashur
RBRupert C.L. Beale
Rupert C.L. Beale
ICImogen A. Clase
Imogen A. Clase
JCJuan J. Carrero
Juan J. Carrero
Management of the global crisis of the coronavirus disease 2019 pandemic requires detailed appraisal of evidence to support clear, actionable, and consistent public health messaging. The use of cloth masks for general public use is being debated, and is in flux. We searched the MEDLINE and EMBASE databases and Google for articles reporting the filtration properties of flat cloth or cloth masks. We reviewed the reference lists of relevant articles to identify further articles and identified articles through social and conventional news media. We found 25 articles. Study of protection for the wearer used healthy volunteers, or used a manikin wearing a mask, with airflow to simulate different breathing rates. Studies of protection of the environment, also known as source control, used convenience samples of healthy volunteers. The design and execution of the studies was generally rigorously described. Many descriptions of cloth lacked the detail required for reproducibility; no study provided all the expected details of material, thread count, weave, and weight. Some of the homemade mask designs were reproducible. Successful masks were made of muslin at 100 threads per inch (TPI) in 3 to 4 layers (4-layer muslin or a muslin-flannel-muslin sandwich), tea towels (also known as dish towels), made using 1 layer (2 layers would be expected to be better), and good-quality cotton T-shirts in 2 layers (with a stitched edge to prevent stretching). In flat-cloth experiments, linen tea towels, 600-TPI cotton in 2 layers, and 600-TPI cotton with 90-TPI flannel performed well but 80-TPI cotton in 2 layers did not. We therefore recommend cotton or flannel at least 100 TPI, at least 2 layers. More layers, 3 or 4, will provide increased filtration but there is a trade-off in that more layers increases the resistance to breathing. Although this is not a systematic review, we included all the articles that we identified in an unbiased way. We did not include gray literature or preprints. A plain language summary of these data and recommendations, as well as information on making, wearing and cleaning cloth masks is available at www.clothmasks.ca.